Search

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 2,441.70 8.65  | 0.36% -12.96% 70.65 20,553.19
NSE Price: Sep 25, 2017 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 25, 2017 2,441.70 8.65 0.36% 2,452.10 2,433.05 15,787 2,402.15 - 2,487.00
BSE Sep 25, 2017 2,426.50 -1.55 -0.06% 2,485.00 2,428.05 3,231 2,400.00 - 2,490.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 11,540 P/B: 10.00 NSE Code: GLAXO
52-Week Range: R 2,201.20 - 3,000.00 Dividend Yield: 1.24% BSE Code: 500660
TTM EPS: R 34.35 Book Value: R 242.57 Face Value: R 10
Price Graph
  • Biocon (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma -10.55 1.81 -1.38 -12.89 -3.12 4.20 8.05
S&P BSE Mid Cap* 29.74 4.58 5.74 17.42 16.43 19.38 8.04
S&P BSE Healthcare* -5.86 8.08 -1.36 -16.85 -0.00 13.49 14.25
Company's return has been calculated on basis of NSE's price.
As on Sep 25, 2017
*As on Sep 22, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 5.71 - -
Net Profit -10.46 - -
EPS -10.46 - -
Book Value -8.08 - -
Average
Operating Margin 16.40 20.79 25.32
Net Margin 10.96 12.27 14.62
Return on Networth 16.08 19.93 22.48
Return on Investment 24.40 30.91 34.11
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -22.53 -13.93 -22.53
Operating Profit -78.01 -70.85 -78.01
Net Profit -76.56 -63.44 -76.56
EPS -76.56 -63.44 -76.56
TTM
Revenue -3.28 0.57 -3.28
Operating Profit -16.48 -26.92 -16.48
Net Profit -13.61 -17.53 -13.61
EPS -13.61 -17.53 -13.61
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 20,553.19 2,896.27 290.93 9.84 16.08 10.00 70.65
Biocon 20,559.00 3,848.20 588.40 14.60 15.15 4.18 39.03
Torrent Pharmaceuticals 20,857.55 5,680.00 830.00 13.87 23.80 4.60 25.13
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 31, 2017 GlaxoSmithKline Pte Ltd  Sell Off Market 3,192,238 2,744.55 87,612.57
Mar 30, 2017 GlaxoSmithK Line Pte Ltd  Buy Off Market 3,192,238 2,731.45 87,194.38
Mar 13, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,533.75 522,200.15
Fund Houses invested in the stock
Fund Jun-17 Mar-17 Dec-16 Sep-16 Jun-16
Aditya Birla Sun Life Mutual Fund 1.645 1.506 1.391 1.263 1.242
UTI Mutual Fund 0.164 0.267 0.279 0.295 0.295
Reliance Mutual Fund 0.005 0.005 0.004 - 0.001
ICICI Prudential Mutual Fund 0.003 0.002 0.002 0.002 0.001
LIC Mutual Fund 0.002 0.002 0.002 0.002 0.002
IDBI Mutual Fund 0.001 0.023 0.057 0.070 0.056
Sundaram Mutual Fund 0.001 0.001 - - -
SBI Mutual Fund 0.001 - - - 0.001
Tata Mutual Fund NA 0.024 0.024 0.024 0.055
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: [email protected]

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.86
Piotroski F-Score
4
Modified C-Score
3
5-Years Price to Earnings
70.65
5-Years Price to Book
10.00
Earnings Yield
EBIT / Enterprise value
2.24%
PEG
Price / Earnings to growth ratio
-5.63
Related Stocks
  Current Price   Chng %
Ajanta Pharma R1,189.65 -1.56%
Alembic Pharmaceuticals R484.65 -1.08%
Alkem Laboratories R1,845.55 +2.48%
Biocon R342.50 -3.60%
Divi's Laboratories R952.70 -1.81%
Glenmark Pharma. R614.70 -2.28%
Jubilant Life Sciences R655.55 -1.06%
Natco Pharma R795.45 -0.40%
Sanofi India R4,000.70 -0.52%
Torrent Pharmaceuticals R1,230.10 -2.52%
As on Sep 25, 2017